person · Reporting owner

Hodges Michelle A

Disclosed activity across 2 companies

Tapewire entity: 67002
SEC CIK: 0001833942

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
QuidelOrtho CorpQDEL · Entity 4986	Chief Legal Officer	February 08, 2026	February 10, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

QuidelOrtho Corp

Report date February 08, 2026 · Filed February 10, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	41,605	Ending reported balance After 2026-02-08 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-02-08 · Grant · Acquired 3,198 · Balance 42,753 F1: Reflects release of restricted stock units that were previously reported on a Form 4. Row 2 · 2026-02-08 · Tax withholding · Disposed 1,148 · Balance 41,605 F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	3,198	Reported balance After 2026-02-08 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2026-02-08 · Exercise / conversion · Disposed 3,198 · Balance 3,198 F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4: 3,197 shares vested on February 8, 2025; 3,198 shares vested on February 8, 2026; and the remaining 3,198 shares will vest on February 8, 2027.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects release of restricted stock units that were previously reported on a Form 4.

F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.

F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

F4: 3,197 shares vested on February 8, 2025; 3,198 shares vested on February 8, 2026; and the remaining 3,198 shares will vest on February 8, 2027.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

QUIDEL CORP /DE/

Report date May 27, 2022 · Filed June 01, 2022

Section 16 reporting ended · disclosed 2022-06-01. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2022-05-27 transaction · row 1 1 source row Row 1 · 2022-05-27 · Disposition to issuer · Disposed 708 · Balance 0 F1: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $188.95 · Expires 2030-12-01	Direct	Reported balance After 2022-05-27 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-05-27 · Disposition to issuer · Disposed 2,105 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: 1,052 shares will vest on December 1, 2022; 526 shares will vest on December 1, 2023; and 527 shares will vest on December 1, 2024.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $254.00 · Expires 2031-02-01	Direct	Reported balance After 2022-05-27 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2022-05-27 · Disposition to issuer · Disposed 1,892 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4: 473 shares are vested in full; the remaining 1,419 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $103.36 · Expires 2032-01-31	Direct	Reported balance After 2022-05-27 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2022-05-27 · Disposition to issuer · Disposed 6,438 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F5: 1,609 shares will vest on each of January 31, 2023 and January 31, 2024; 1,610 shares will vest on each of January 31, 2025 and January 31, 2026.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2022-05-27 · Disposition to issuer · Disposed 714 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F8: 714 shares will vest in equal installments on December 1, 2022, December 1, 2023 and December 1, 2024.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2022-05-27 · Disposition to issuer · Disposed 1,420 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F9: 473 shares will vest on each of February 1, 2023 and February 1, 2024; 474 shares will vest on February 1, 2025.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2022-05-27 · Disposition to issuer · Disposed 1,260 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F10: 1,260 shares will vest in equal installments on May 25, 2023, May 25, 2024 and May 25, 2025.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2022-05-27 · Disposition to issuer · Disposed 1,559 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F11: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2022-05-27 · Disposition to issuer · Disposed 11,910 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: 11,910 shares will vest in equal installments on November 8, 2022, November 8, 2023 and November 8, 2024.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2022-05-27 · Disposition to issuer · Disposed 6,439 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13: 1,609 shares will vest on January 31, 2023; the remaining 4,830 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2022-05-27 · Disposition to issuer · Disposed 7,256 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F14: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2022-05-27 · Disposition to issuer · Disposed 1,020 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2022-05-27 · Disposition to issuer · Disposed 204 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F16: 204 shares will vest on January 31, 2023.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.

F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3: 1,052 shares will vest on December 1, 2022; 526 shares will vest on December 1, 2023; and 527 shares will vest on December 1, 2024.

F4: 473 shares are vested in full; the remaining 1,419 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.

F5: 1,609 shares will vest on each of January 31, 2023 and January 31, 2024; 1,610 shares will vest on each of January 31, 2025 and January 31, 2026.

F6: Each restricted stock unit represents the right to receive one share of Quidel common stock.

F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F8: 714 shares will vest in equal installments on December 1, 2022, December 1, 2023 and December 1, 2024.

F9: 473 shares will vest on each of February 1, 2023 and February 1, 2024; 474 shares will vest on February 1, 2025.

F10: 1,260 shares will vest in equal installments on May 25, 2023, May 25, 2024 and May 25, 2025.

F11: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025.

F12: 11,910 shares will vest in equal installments on November 8, 2022, November 8, 2023 and November 8, 2024.

F13: 1,609 shares will vest on January 31, 2023; the remaining 4,830 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026.

F14: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026.

F15: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F16: 204 shares will vest on January 31, 2023.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
January 31, 2023 Filed Feb 2, 2023 17:57 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantCommon Stock	1,609	$0.00	$0.00	Disclosure SEC source: 0001209191-23-006325 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,633 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document
December 01, 2022 Filed Dec 5, 2022 16:05 UTC	QuidelOrtho Corp QDEL · Entity 4986	Exercise / conversionRestricted Stock Units · Derivative	238	$0.00	$0.00	Disclosure SEC source: 0001209191-22-059643 · doc4.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 476 Underlying: Common Stock · 238 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 238 shares vested on December 1, 2022; the remaining 476 shares will vest in equal installments on December 1, 2023 and December 1, 2024. F4 · derivative.expiration_date: 238 shares vested on December 1, 2022; the remaining 476 shares will vest in equal installments on December 1, 2023 and December 1, 2024. Read SEC document
December 01, 2022 Filed Dec 5, 2022 16:05 UTC	QuidelOrtho Corp QDEL · Entity 4986	Tax withholdingCommon Stock	119	$93.65	$11,144.35	Disclosure SEC source: 0001209191-22-059643 · doc4.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,024 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
December 01, 2022 Filed Dec 5, 2022 16:05 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantCommon Stock	238	$0.00	$0.00	Disclosure SEC source: 0001209191-22-059643 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,143 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document
November 08, 2022 Filed Nov 10, 2022 16:05 UTC	QuidelOrtho Corp QDEL · Entity 4986	Exercise / conversionRestricted Stock Units · Derivative	3,970	$0.00	$0.00	Disclosure SEC source: 0001209191-22-056365 · doc4.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,940 Underlying: Common Stock · 3,970 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 3,970 shares vested on November 8, 2022; the remaining 7,940 shares will vest in equal installments on November 8, 2023 and November 8, 2024. F4 · derivative.expiration_date: 3,970 shares vested on November 8, 2022; the remaining 7,940 shares will vest in equal installments on November 8, 2023 and November 8, 2024. Read SEC document
November 08, 2022 Filed Nov 10, 2022 16:05 UTC	QuidelOrtho Corp QDEL · Entity 4986	Tax withholdingCommon Stock	1,969	$87.69	$172,661.61	Disclosure SEC source: 0001209191-22-056365 · doc4.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,905 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
November 08, 2022 Filed Nov 10, 2022 16:05 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantCommon Stock	3,970	$0.00	$0.00	Disclosure SEC source: 0001209191-22-056365 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,874 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document
October 15, 2022 Filed Oct 17, 2022 16:33 UTC	QuidelOrtho Corp QDEL · Entity 4986	Exercise / conversionRestricted Stock Units · Derivative	389	$0.00	$0.00	Disclosure SEC source: 0001209191-22-053824 · doc4.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,170 Underlying: Common Stock · 389 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 389 shares vested on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025. F4 · derivative.expiration_date: 389 shares vested on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025. Read SEC document
October 15, 2022 Filed Oct 17, 2022 16:33 UTC	QuidelOrtho Corp QDEL · Entity 4986	Tax withholdingCommon Stock	193	$76.29	$14,723.97	Disclosure SEC source: 0001209191-22-053824 · doc4.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 904 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
October 15, 2022 Filed Oct 17, 2022 16:33 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantCommon Stock	389	$0.00	$0.00	Disclosure SEC source: 0001209191-22-053824 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,097 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document
May 27, 2022 Filed Jun 1, 2022 16:25 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Disposition to issuerRestricted Stock Units · Derivative	204	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020404 · doc4.xml · derivative · entry 13 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 204 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F16 · derivative.exercise_date: 204 shares will vest on January 31, 2023. F15 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F16 · derivative.expiration_date: 204 shares will vest on January 31, 2023. Read SEC document
May 27, 2022 Filed Jun 1, 2022 16:25 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Disposition to issuerRestricted Stock Units · Derivative	1,020	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020404 · doc4.xml · derivative · entry 12 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,020 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F15 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. Read SEC document
May 27, 2022 Filed Jun 1, 2022 16:25 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Disposition to issuerRestricted Stock Units · Derivative	7,256	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020404 · doc4.xml · derivative · entry 11 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,256 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F14 · derivative.exercise_date: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. F14 · derivative.expiration_date: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. Read SEC document
May 27, 2022 Filed Jun 1, 2022 16:25 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Disposition to issuerRestricted Stock Units · Derivative	6,439	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020404 · doc4.xml · derivative · entry 10 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,439 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13 · derivative.exercise_date: 1,609 shares will vest on January 31, 2023; the remaining 4,830 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026. F13 · derivative.expiration_date: 1,609 shares will vest on January 31, 2023; the remaining 4,830 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026. Read SEC document
May 27, 2022 Filed Jun 1, 2022 16:25 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Disposition to issuerRestricted Stock Units · Derivative	11,910	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020404 · doc4.xml · derivative · entry 9 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,910 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12 · derivative.exercise_date: 11,910 shares will vest in equal installments on November 8, 2022, November 8, 2023 and November 8, 2024. F12 · derivative.expiration_date: 11,910 shares will vest in equal installments on November 8, 2022, November 8, 2023 and November 8, 2024. Read SEC document
May 27, 2022 Filed Jun 1, 2022 16:25 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Disposition to issuerRestricted Stock Units · Derivative	1,559	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020404 · doc4.xml · derivative · entry 8 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,559 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F11 · derivative.exercise_date: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025. F11 · derivative.expiration_date: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025. Read SEC document
May 27, 2022 Filed Jun 1, 2022 16:25 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Disposition to issuerRestricted Stock Units · Derivative	1,260	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020404 · doc4.xml · derivative · entry 7 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,260 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F10 · derivative.exercise_date: 1,260 shares will vest in equal installments on May 25, 2023, May 25, 2024 and May 25, 2025. F10 · derivative.expiration_date: 1,260 shares will vest in equal installments on May 25, 2023, May 25, 2024 and May 25, 2025. Read SEC document
May 27, 2022 Filed Jun 1, 2022 16:25 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Disposition to issuerRestricted Stock Units · Derivative	1,420	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020404 · doc4.xml · derivative · entry 6 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,420 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F9 · derivative.exercise_date: 473 shares will vest on each of February 1, 2023 and February 1, 2024; 474 shares will vest on February 1, 2025. F9 · derivative.expiration_date: 473 shares will vest on each of February 1, 2023 and February 1, 2024; 474 shares will vest on February 1, 2025. Read SEC document
May 27, 2022 Filed Jun 1, 2022 16:25 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Disposition to issuerRestricted Stock Units · Derivative	714	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020404 · doc4.xml · derivative · entry 5 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 714 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F8 · derivative.exercise_date: 714 shares will vest in equal installments on December 1, 2022, December 1, 2023 and December 1, 2024. F8 · derivative.expiration_date: 714 shares will vest in equal installments on December 1, 2022, December 1, 2023 and December 1, 2024. Read SEC document
May 27, 2022 Filed Jun 1, 2022 16:25 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Disposition to issuerNon-Qualified Stock Options · Derivative	6,438	$0.00 Strike: $103.36	$0.00	Disclosure SEC source: 0000899243-22-020404 · doc4.xml · derivative · entry 4 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,438 shares Expires 2032-01-31 F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F5 · derivative.exercise_date: 1,609 shares will vest on each of January 31, 2023 and January 31, 2024; 1,610 shares will vest on each of January 31, 2025 and January 31, 2026. Read SEC document
May 27, 2022 Filed Jun 1, 2022 16:25 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Disposition to issuerNon-Qualified Stock Options · Derivative	1,892	$0.00 Strike: $254.00	$0.00	Disclosure SEC source: 0000899243-22-020404 · doc4.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,892 shares Expires 2031-02-01 F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4 · derivative.exercise_date: 473 shares are vested in full; the remaining 1,419 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025. Read SEC document
May 27, 2022 Filed Jun 1, 2022 16:25 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Disposition to issuerNon-Qualified Stock Options · Derivative	2,105	$0.00 Strike: $188.95	$0.00	Disclosure SEC source: 0000899243-22-020404 · doc4.xml · derivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,105 shares Expires 2030-12-01 F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3 · derivative.exercise_date: 1,052 shares will vest on December 1, 2022; 526 shares will vest on December 1, 2023; and 527 shares will vest on December 1, 2024. Read SEC document
May 27, 2022 Filed Jun 1, 2022 16:25 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Disposition to issuerCommon Stock	708	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-22-020404 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho. F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:36 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantRestricted Stock Units · Derivative	204	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 13 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204 Underlying: Common Stock · 204 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F16 · derivative.exercise_date: 204 shares will vest on January 31, 2023. F15 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F16 · derivative.expiration_date: 204 shares will vest on January 31, 2023. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:36 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantRestricted Stock Units · Derivative	1,020	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 12 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,020 Underlying: Common Stock · 1,020 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F15 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:36 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantRestricted Stock Units · Derivative	7,256	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 11 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,256 Underlying: Common Stock · 7,256 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F14 · derivative.exercise_date: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. F14 · derivative.expiration_date: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:36 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantRestricted Stock Units · Derivative	6,439	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 10 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,439 Underlying: Common Stock · 6,439 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13 · derivative.exercise_date: 1,609 shares will vest on January 31, 2023; the remaining 4,830 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026. F13 · derivative.expiration_date: 1,609 shares will vest on January 31, 2023; the remaining 4,830 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:36 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantRestricted Stock Units · Derivative	11,910	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 9 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,910 Underlying: Common Stock · 11,910 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12 · derivative.exercise_date: 11,910 shares will vest in equal installments on November 8, 2022, November 8, 2023 and November 8, 2024. F12 · derivative.expiration_date: 11,910 shares will vest in equal installments on November 8, 2022, November 8, 2023 and November 8, 2024. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:36 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantRestricted Stock Units · Derivative	1,559	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 8 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,559 Underlying: Common Stock · 1,559 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F11 · derivative.exercise_date: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025. F11 · derivative.expiration_date: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:36 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantRestricted Stock Units · Derivative	1,260	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 7 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,260 Underlying: Common Stock · 1,260 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F10 · derivative.exercise_date: 1,260 shares will vest in equal installments on May 25, 2023, May 25, 2024 and May 25, 2025. F10 · derivative.expiration_date: 1,260 shares will vest in equal installments on May 25, 2023, May 25, 2024 and May 25, 2025. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:36 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantRestricted Stock Units · Derivative	1,420	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 6 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,420 Underlying: Common Stock · 1,420 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F9 · derivative.exercise_date: 473 shares will vest on each of February 1, 2023 and February 1, 2024; 474 shares will vest on February 1, 2025. F9 · derivative.expiration_date: 473 shares will vest on each of February 1, 2023 and February 1, 2024; 474 shares will vest on February 1, 2025. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:36 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantRestricted Stock Units · Derivative	714	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 5 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 714 Underlying: Common Stock · 714 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F8 · derivative.exercise_date: 714 shares will vest in equal installments on December 1, 2022, December 1, 2023 and December 1, 2024. F8 · derivative.expiration_date: 714 shares will vest in equal installments on December 1, 2022, December 1, 2023 and December 1, 2024. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:36 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantNon-Qualified Stock Options · Derivative	6,438	$0.00 Strike: $103.36	$0.00	Disclosure SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 4 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,438 Underlying: Common Stock · 6,438 shares Expires 2032-01-31 F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F5 · derivative.exercise_date: 1,609 shares will vest on each of January 31, 2023 and January 31, 2024; 1,610 shares will vest on each of January 31, 2025 and January 31, 2026. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:36 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantNon-Qualified Stock Options · Derivative	1,892	$0.00 Strike: $254.00	$0.00	Disclosure SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,892 Underlying: Common Stock · 1,892 shares Expires 2031-02-01 F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4 · derivative.exercise_date: 473 shares are vested in full; the remaining 1,419 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:36 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantNon-Qualified Stock Options · Derivative	2,105	$0.00 Strike: $188.95	$0.00	Disclosure SEC source: 0000899243-22-020491 · doc4.xml · derivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,105 Underlying: Common Stock · 2,105 shares Expires 2030-12-01 F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3 · derivative.exercise_date: 1,052 shares will vest on December 1, 2022; 526 shares will vest on December 1, 2023; and 527 shares will vest on December 1, 2024. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:36 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantCommon Stock	708	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-22-020491 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 708 F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho. F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho. Read SEC document
May 25, 2022 Filed May 26, 2022 16:11 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionRestricted Stock Units · Derivative	420	$0.00	$0.00	Disclosure SEC source: 0001209191-22-032177 · doc4.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,260 Underlying: Common Stock · 420 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F4 · derivative.exercise_date: One-quarter of the shares subject to the original grant vest annually over a four-year period, commencing on the first anniversary date of the grant date. F4 · derivative.expiration_date: One-quarter of the shares subject to the original grant vest annually over a four-year period, commencing on the first anniversary date of the grant date. Read SEC document
May 25, 2022 Filed May 26, 2022 16:11 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	146	$98.99	$14,452.54	Disclosure SEC source: 0001209191-22-032177 · doc4.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 708 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
May 25, 2022 Filed May 26, 2022 16:11 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	420	$0.00	$0.00	Disclosure SEC source: 0001209191-22-032177 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 854 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document
February 01, 2022 Filed Feb 2, 2022 21:56 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionRestricted Stock Units · Derivative	473	$0.00	$0.00	Disclosure SEC source: 0001209191-22-006635 · doc4.xml · derivative · entry 8 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,420 Underlying: Common Stock · 473 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F10 · derivative.exercise_date: One-quarter of the shares subject to the original grant vest annually over a four-year period, commencing on the first anniversary date of the grant date. F10 · derivative.expiration_date: One-quarter of the shares subject to the original grant vest annually over a four-year period, commencing on the first anniversary date of the grant date. Read SEC document
February 01, 2022 Filed Feb 2, 2022 21:56 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	194	$102.32	$19,850.08	Disclosure SEC source: 0001209191-22-006635 · doc4.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 434 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 01, 2022 Filed Feb 2, 2022 21:56 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	473	$0.00	$0.00	Disclosure SEC source: 0001209191-22-006635 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 628 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document
January 31, 2022 Filed Feb 2, 2022 21:56 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units (Premium) · Derivative	204	$0.00	$0.00	Disclosure SEC source: 0001209191-22-006635 · doc4.xml · derivative · entry 7 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204 Underlying: Common Stock · 204 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F7 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F9 · derivative.exercise_date: The restricted stock units vest on January 31, 2023. F7 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F9 · derivative.expiration_date: The restricted stock units vest on January 31, 2023. Read SEC document
January 31, 2022 Filed Feb 2, 2022 21:56 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units (Converted) · Derivative	1,020	$0.00	$0.00	Disclosure SEC source: 0001209191-22-006635 · doc4.xml · derivative · entry 6 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,020 Underlying: Common Stock · 1,020 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F7 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F8 · derivative.exercise_date: The restricted stock units vest on January 31, 2022. F7 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F8 · derivative.expiration_date: The restricted stock units vest on January 31, 2022. Read SEC document
January 31, 2022 Filed Feb 2, 2022 21:56 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units · Derivative	7,256	$0.00	$0.00	Disclosure SEC source: 0001209191-22-006635 · doc4.xml · derivative · entry 5 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,256 Underlying: Common Stock · 7,256 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F6 · derivative.exercise_date: 3,628 shares vest on the second anniversary date of the grant date, January 31, 2024; 1,814 shares vest on the third anniversary date of the grant date, January 31, 2025; and 1,814 shares vest on the fourth anniversary date of the grant date, January 31, 2026. F6 · derivative.expiration_date: 3,628 shares vest on the second anniversary date of the grant date, January 31, 2024; 1,814 shares vest on the third anniversary date of the grant date, January 31, 2025; and 1,814 shares vest on the fourth anniversary date of the grant date, January 31, 2026. Read SEC document
January 31, 2022 Filed Feb 2, 2022 21:56 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units · Derivative	6,439	$0.00	$0.00	Disclosure SEC source: 0001209191-22-006635 · doc4.xml · derivative · entry 4 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,439 Underlying: Common Stock · 6,439 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F5 · derivative.exercise_date: 1,609 shares vest on the first anniversary date of the grant date, January 31, 2023; 1,610 shares vest on the second anniversary date of the grant date, January 31, 2024; 1,610 shares vest on the third anniversary date of the grant date, January 31, 2025; and 1,610 shares vest on the fourth anniversary date of the grant date, January 31, 2026. F5 · derivative.expiration_date: 1,609 shares vest on the first anniversary date of the grant date, January 31, 2023; 1,610 shares vest on the second anniversary date of the grant date, January 31, 2024; 1,610 shares vest on the third anniversary date of the grant date, January 31, 2025; and 1,610 shares vest on the fourth anniversary date of the grant date, January 31, 2026. Read SEC document
January 31, 2022 Filed Feb 2, 2022 21:56 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantNon-Qualified Stock Option · Derivative	6,438	$0.00 Strike: $103.36	$0.00	Disclosure SEC source: 0001209191-22-006635 · doc4.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,438 Underlying: Common Stock · 6,438 shares Expires 2032-01-31 F3 · derivative.exercise_date: 1,609 shares vest on the first anniversary date of the grant date, January 31, 2023; 1,609 shares vest on the second anniversary date of the grant date, January 31, 2024; 1,610 shares vest on the third anniversary date of the grant date, January 31, 2025; and 1,610 shares vest on the fourth anniversary date of the grant date, January 31, 2026. Read SEC document
December 01, 2021 Filed Dec 3, 2021 19:46 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionRestricted Stock Units · Derivative	238	$0.00	$0.00	Disclosure SEC source: 0001209191-21-068012 · doc4.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 714 Underlying: Common Stock · 238 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: 238 shares vested on December 1, 2021; 238 shares will vest on December 1, 2022; 238 shares will vest on December 1, 2023; and 238 shares will vest on December 1, 2024. F4 · derivative.expiration_date: 238 shares vested on December 1, 2021; 238 shares will vest on December 1, 2022; 238 shares will vest on December 1, 2023; and 238 shares will vest on December 1, 2024. Read SEC document
December 01, 2021 Filed Dec 3, 2021 19:46 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	83	$144.69	$12,009.27	Disclosure SEC source: 0001209191-21-068012 · doc4.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
December 01, 2021 Filed Dec 3, 2021 19:46 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	238	$0.00	$0.00	Disclosure SEC source: 0001209191-21-068012 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.